IO Biotech Inc. (IOBT)
IO Biotech, Inc. - IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination withKEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma
IO Biotech Inc. (IOBT)
IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma
9 Meters Biopharma, Inc. (NMTRQ)
Best AirPrint Printer Models for Home and Office Use
9 Meters Biopharma, Inc. (NMTRQ)
Best Beats Headphones In 2025
9 Meters Biopharma, Inc. (NMTRQ)
Best Portable Wireless Bluetooth Speakers In Terms Of Bass
9 Meters Biopharma, Inc. (NMTRQ)
Best Budget Gaming Laptops for Performance in 2025
9 Meters Biopharma, Inc. (NMTRQ)
Best Bluetooth Speakers Under $100 (2025)
Eli Lilly and Company (LLY)
Lilly launches "The Court Is Hers™" to help more girls get in the game
RxSight Inc. (RXST)
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit
Estrella Immunopharma Inc. (ESLAW)
Sarepta Therapeutics Inc (SRPT)
SRPT INVESTOR NOTICE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit